OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET
OptimizeRx (Nasdaq: OPRX), a leading provider of healthcare technology solutions for life sciences companies, has scheduled its Fourth Quarter and Full Year 2024 financial results conference call for March 12, 2025, at 8:30 a.m. ET. The company will release its financial results for the quarter ended December 31, 2024, via press release before the conference call. Management will host the call followed by a Q&A session. A replay will be accessible for 12 months through the Investors section of the OptimizeRx website.
OptimizeRx (Nasdaq: OPRX), un fornitore leader di soluzioni tecnologiche sanitarie per aziende nel settore delle scienze della vita, ha programmato la sua conferenza sui risultati finanziari del Quarto Trimestre e dell'Anno Completo 2024 per il 12 marzo 2025, alle 8:30 a.m. ET. L'azienda rilascerà i risultati finanziari per il trimestre conclusosi il 31 dicembre 2024, tramite comunicato stampa prima della conferenza. La direzione condurrà la chiamata seguita da una sessione di domande e risposte. Una registrazione sarà accessibile per 12 mesi attraverso la sezione Investitori del sito web di OptimizeRx.
OptimizeRx (Nasdaq: OPRX), un proveedor líder de soluciones tecnológicas de salud para empresas de ciencias de la vida, ha programado su conferencia sobre los resultados financieros del Cuarto Trimestre y del Año Completo 2024 para el 12 de marzo de 2025, a las 8:30 a.m. ET. La compañía publicará sus resultados financieros para el trimestre que finalizó el 31 de diciembre de 2024, a través de un comunicado de prensa antes de la conferencia. La dirección llevará a cabo la llamada seguida de una sesión de preguntas y respuestas. Una grabación estará disponible durante 12 meses a través de la sección de Inversores del sitio web de OptimizeRx.
OptimizeRx (Nasdaq: OPRX), 생명과학 기업을 위한 의료 기술 솔루션의 선도적인 제공업체가 2024년 4분기 및 전체 연도 재무 결과 컨퍼런스 콜을 2025년 3월 12일 오전 8시 30분 ET에 예정하였습니다. 이 회사는 2024년 12월 31일로 종료된 분기의 재무 결과를 컨퍼런스 콜 전에 보도 자료를 통해 발표할 것입니다. 경영진이 콜을 진행한 후 질문 및 답변 세션이 이어질 것입니다. 녹음은 OptimizeRx 웹사이트의 투자자 섹션을 통해 12개월 동안 접근 가능합니다.
OptimizeRx (Nasdaq: OPRX), un fournisseur leader de solutions technologiques de santé pour les entreprises des sciences de la vie, a programmé sa conférence sur les résultats financiers du quatrième trimestre et de l'année complète 2024 pour le 12 mars 2025 à 8h30 ET. L'entreprise publiera ses résultats financiers pour le trimestre clos le 31 décembre 2024, par communiqué de presse avant la conférence. La direction animera la conférence suivie d'une session de questions-réponses. Un enregistrement sera accessible pendant 12 mois via la section Investisseurs du site web d'OptimizeRx.
OptimizeRx (Nasdaq: OPRX), ein führender Anbieter von Gesundheitstechnologielösungen für Unternehmen der Lebenswissenschaften, hat seine Konferenz zur finanziellen Ergebnisbekanntgabe für das vierte Quartal und das Gesamtjahr 2024 für den 12. März 2025 um 8:30 Uhr ET angesetzt. Das Unternehmen wird seine finanziellen Ergebnisse für das zum 31. Dezember 2024 abgeschlossene Quartal vor der Konferenz per Pressemitteilung veröffentlichen. Das Management wird die Konferenz leiten, gefolgt von einer Frage- und Antwortsitzung. Eine Aufzeichnung wird für 12 Monate über den Investorenbereich der OptimizeRx-Website zugänglich sein.
- None.
- None.
WALTHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, will hold a conference call on Wednesday, March 12, 2025, at 8:30 a.m. Eastern Time to discuss full year fiscal 2024 financial results and the fourth quarter period ended December 31, 2024. The financial results will be issued in a press release prior to the call.
OptimizeRx management will host the call, followed by a question-and-answer period. Details for the conference call can be found below:
| Date: | Wednesday, March 12, 2025 |
| Time: | 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time) |
| Toll Free: | 1-844-825-9789 |
| International: | 1-412-317-5180 |
| Conference ID: | 2202248 |
| Call Me Link: | https://callme.viavid.com/?$Y2FsbG1lPXRydWUmcGFzc2NvZGU9JmluZm89Y29tcGFueSZyPXRydWUmYj0xNg== |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1708545&tp_key=86684771bf |
Please call the conference telephone number or log on to the web access link five minutes prior to the start time.
A replay of the call will remain available for 12 months via the Investors section of the OptimizeRx website at http://www.optimizerx.com/investors.
About OptimizeRx
OptimizeRx provides trailblazing technology that fosters care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the healthcare journey. With the ability to synchronize messaging across 2 million healthcare providers and over 240 million adults across a multitude of digital channels including a proprietary point-of-care network, OptimizeRx is changing the way life sciences engage with customers.
For more information, follow the Company on X, LinkedIn or visit www.optimizerx.com.
OptimizeRx Contact
Andy D’Silva, SVP Corporate Finance
adsilva@optimizerx.com
Investor Relations Contact
Sandya von der Weid
LifeSci Advisors, LLC
svonderweid@lifesciadvisors.com
FAQ
When will OptimizeRx (OPRX) release its Q4 2024 earnings?
How can investors access OptimizeRx's (OPRX) Q4 2024 earnings call?
How long will OptimizeRx's (OPRX) Q4 2024 earnings call replay be available?
What period will OptimizeRx's (OPRX) upcoming earnings report cover?
